Cambrian BioPharma Inc - 30 Dec 2021 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
10%+ Owner
Signature
Cambrian BioPharma Inc, by: /s/ James Peyer
Issuer symbol
SNSE
Transactions as of
30 Dec 2021
Transactions value $
$5,466
Form type
4
Filing time
03 Jan 2022, 08:38:24 UTC
Previous filing
30 Dec 2021
Next filing
11 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Purchase $5.47K +1.13K +0.02% $4.85* 4.92M 30 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Cambrian Biopharma Inc, a Delaware corporation ("Cambrian"). The Chief Executive Officer of Cambrian, James Peyer, may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.